Stock Market Reviews

Read and share opinions on IPSC (Century Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

Latest News

• Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
  Nov 13, 2025
• Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes
  Nov 13, 2025
• Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
  Oct 14, 2025
• Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
  Aug 22, 2025
• All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy
  Jul 21, 2025
• Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock
  Jul 15, 2025
• Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum
  Jun 25, 2025
• Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
  Jun 6, 2025
• Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
  May 28, 2025
• Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates
  May 16, 2025
• Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
  May 15, 2025
• Century Therapeutics, Inc. (IPSC) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
  May 1, 2025
• Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
  Apr 28, 2025
• Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
  Apr 15, 2025
• Century Therapeutics (IPSC) Upgraded to Buy: What Does It Mean for the Stock?
  Mar 25, 2025
• Century Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
  Mar 21, 2025
• Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates
  Mar 19, 2025
• Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
  Mar 19, 2025